Highbridge Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-34,627	Closed	-$598K	–	910
2017 Q1	$598K	Buy	34,627 +20,246	+141%	+$350K	0.01%	661
2016 Q4	$158K	Buy	+14,381	New	+$158K	﹤0.01%	926